Product Images Amoxicillin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Amoxicillin NDC 0143-9285 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - amoxicillin tablets usp 875 mg 1

Table 1 - amoxicillin tablets usp 875 mg 1

This text provides dosing recommendations for the antibiotic Amoxicillin for the treatment of various bacterial infections in adult and pediatric patients over 3 months of age. The recommended doses vary depending on the severity and location of the infection, with higher doses for severe cases. The text also includes specific dosing guidance for the treatment of uncomplicated genital infections caused by Gonorrhea. Children weighing less than 40 kg should be given a lower dose, based on their weight, while those weighing over 40 kg should follow the adult recommendations.*

structural image - amoxicillin tablets usp 875 mg 2

structural image - amoxicillin tablets usp 875 mg 2

Table 3 - amoxicillin tablets usp 875 mg 3

Table 3 - amoxicillin tablets usp 875 mg 3

This is a table showing the pharmacokinetic parameters of Amoxicillin in healthy adults who were administered doses of 400mg/5mL suspension and 400mg chewable tablets. The table shows the mean values of AUC (area under the curve) and Cha (concentration of the drug in the blood) for both forms of administration. The dose was given at the start of a light meal and peak concentrations occurred approximately 1 hour after the dose.*

Bacteria - amoxicillin tablets usp 875 mg 4

Bacteria - amoxicillin tablets usp 875 mg 4

Table 4 - amoxicillin tablets usp 875 mg 5

Table 4 - amoxicillin tablets usp 875 mg 5

This is a table showing the results of two studies on the use of amoxicillin as part of a triple therapy for eradicating H. pylori infection in patients with confirmed duodenal ulcers. The table presents two types of analyses: Evaluable Analysis and Intent-to-Treat Analysis. The number of patients included in each study and the corresponding eradication rates with their respective 95% confidence intervals are provided for each analysis. The text also clarifies that patients were included in the analysis only if they had confirmed H. pylori infection at baseline and a confirmed duodenal ulcer. Any dropouts due to adverse events related to the study drug were also considered as therapy failures.*

Table 5 - amoxicillin tablets usp 875 mg 6

Table 5 - amoxicillin tablets usp 875 mg 6

Table 6 - amoxicillin tablets usp 875 mg 7

Table 6 - amoxicillin tablets usp 875 mg 7

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.